Showing results (501-510 of 1,276) with videos related to
Sort By:
Pageof 128
JACC. Cardiovascular Interventions|August 20, 2021
Impact of Echocardiographic Guidance on Safety and Efficacy of Left Atrial Appendage Closure: An Observational StudyRoberto Galea, Lorenz Räber, Monika Fuerholz, et al.JACC. Cardiovascular Interventions|August 20, 2013
Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysisGert Richardt, Matthias Leschke, Mohamed Abdel-Wahab, et al.Journal of the American Heart Association|August 15, 2023
Amyloid Transthyretin Cardiomyopathy in Elderly Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve ImplantationStephan Dobner, Thomas Pilgrim, Daniel Hagemeyer, et al.JACC. Cardiovascular Interventions|July 30, 2025
Atrioventricular Conduction Disturbances in Patients Undergoing Transcatheter Tricuspid Valve Intervention: A Multidisciplinary ConsensusQuentin Fischer, Kenneth A Ellenbogen, Suneet Mittal, et al.The American Journal of Cardiology|October 16, 2020
Meta-Analysis of Bioprosthetic Valve Thrombosis After Transcatheter Aortic Valve ImplantationTobias Rheude, Costanza Pellegrini, Stefan Stortecky, et al.JACC. Cardiovascular Interventions|May 7, 2015
European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT RegistryGerhard Schymik, Thierry Lefèvre, Antonio L Bartorelli, et al.JACC. Advances|November 4, 2024
Apixaban and Limiting Aspirin for Patients With Atrial Fibrillation, Percutaneous Coronary Intervention, and MultimorbidityKonstantin A Krychtiuk, Renato D Lopes, Daniel M Wojdyla, et al.American Heart Journal|November 18, 2024
Effect of apixaban versus vitamin K antagonist and aspirin versus placebo on days alive and out of hospital: An analysis from AUGUSTUSAlexander C Fanaroff, Amit N Vora, Daniel M Wojdyla, et al.Circulation. Cardiovascular Interventions|January 10, 2016
Safety and Efficacy of New-Generation Drug-Eluting Stents in Women at High Risk for Atherothrombosis: From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled AnalysisGennaro Giustino, Usman Baber, Olga Salianski, et al.JACC. Cardiovascular Interventions|April 9, 2016
Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization: From the WIN-DES Collaborative Patient-Level Pooled AnalysisGennaro Giustino, Usman Baber, Melissa Aquino, et al.Pageof 128